Evidence map›Paper›PMID 37445790›Full record

ReviewInternational journal of molecular sciences2023

A State-of-Art Review of the Vicious Circle of Sleep Disorders, Diabetes and Neurodegeneration Involving Metabolism and Microbiota Alterations.

Salvatore Versace, Gaia Pellitteri, Roberto Sperotto, Sara Tartaglia, Andrea Da Porto, Cristiana Catena, Gian Luigi Gigli, Alessandro Cavarape, Mariarosaria Valente

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Unraveling the Effects ofInternational journal of molecular sciences · 2025
    Review
  4. Review
  5. The Role ofJournal of clinical medicine · 2024
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Salvatore VersaceClinical Neurology, Udine University Hospital, Piazza Santa Maria della Misericordia, 15, 33100 Udine, Italy.ORCID 0009-0001-1807-7589
Gaia PellitteriClinical Neurology, Udine University Hospital, Piazza Santa Maria della Misericordia, 15, 33100 Udine, Italy.ORCID 0000-0001-9048-7227
Roberto SperottoClinical Neurology, Udine University Hospital, Piazza Santa Maria della Misericordia, 15, 33100 Udine, Italy.
Sara TartagliaClinical Neurology, Udine University Hospital, Piazza Santa Maria della Misericordia, 15, 33100 Udine, Italy.
Andrea Da PortoDepartment of Medicine (DAME), University of Udine, 33100 Udine, Italy.ORCID 0000-0001-9995-0169
Cristiana CatenaDepartment of Medicine (DAME), University of Udine, 33100 Udine, Italy.
Gian Luigi GigliDepartment of Medicine (DAME), University of Udine, 33100 Udine, Italy.
Alessandro CavarapeDepartment of Medicine (DAME), University of Udine, 33100 Udine, Italy.ORCID 0000-0003-2726-5714
Mariarosaria ValenteClinical Neurology, Udine University Hospital, Piazza Santa Maria della Misericordia, 15, 33100 Udine, Italy.
University of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the context of neurodegenerative disorders, cognitive decline is frequently reported in older population. Recently, numerous metabolic pathways have been implicated in neurodegeneration, including signaling disruption of insulin and other glucose-regulating hormones. In fact, Alzheimer's disease has now been considered as "type-3 diabetes". In this review, we tried to clarify the role of sleep impairment as the third major player in the complex relationship between metabolic and neurodegenerative diseases. Altered sleep may trigger or perpetuate these vicious mechanisms, leading to the development of both dementia and type 2 diabetes mellitus. Finally, we analyzed these reciprocal interactions considering the emerging role of the gut microbiota in modulating the same processes. Conditions of dysbiosis have been linked to circadian rhythm disruption, metabolic alterations, and release of neurotoxic products, all contributing to neurodegeneration. In a future prospective, gut microbiota could provide a major contribution in explaining the tangled relationship between sleep disorders, dementia and diabetes.

Indexed as

Alzheimer DiseaseDiabetes Mellitus, Type 2Gastrointestinal MicrobiomeMicrobiotaSleep Wake DisordersAgedBrainDysbiosisHumansAlzheimer’s diseasebrain–gut axiscognitiondiabetesgut microbiotainflammationinsulin resistanceneurodegenerationsleep disorders

Identifiers

PMID37445790
PMCPMC10341533
OpenAlexW4382137573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.